FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

GOLDMAN SACHS GROUP INC
2. Issuer Name and Ticker or Trading Symbol

CORE LABORATORIES N V [ CLB ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

200 WEST STREET
3. Date of Earliest Transaction (MM/DD/YYYY)

4/1/2020
(Street)

NEW YORK, NY 10282
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares (1)4/1/2020  P  376 A$9.41 4640600 I Through Subsidiary (2)(3)
Common Shares (1)4/1/2020  P  300 A$9.25 4640900 I Through Subsidiary (2)(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Equity Swap (4) (4)4/1/2020  S     1176   (4)11/15/2023 Common Shares 1176  (4)1176 (4)I Through Subsidiary (2)(3)
Equity Swap (5) (5)4/1/2020  P   93     (5)8/13/2029 Common Shares 93  (5)93 (5)I Through Subsidiary (2)(3)

Explanation of Responses:
(1) The amount of profit recoverable by the Issuer from the reported transactions will be remitted to the Issuer.
(2) This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs & Co. LLC. ("Goldman Sachs" and, together with GS Group, the "Reporting Persons". Goldman Sachs is a wholly-owned subsidiary of GS Group. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein. On April 1, 2020, the Reporting Persons ceased to be a greater than 10% beneficial owner of the Issuer's Common Shares but did not experience a change in their pecuniary interest in the Issuer.
(3) GS Group may be deemed to beneficially own indirectly the Common Shares by reason of Goldman Sachs' direct beneficial ownership.
(4) Goldman Sachs entered into an equity swap agreement which, upon the termination of the agreement on 11/15/2023, Goldman Sachs will pay to the counterparty any increase in the price of the Common Shares above $9.29 per share and the counterparty will pay to Goldman Sachs any decrease in the price of the Common Shares below $9.29 per share, in each case, based on a notional amount of 1,176 Common Shares and any additional costs and charges including any payments with respect to financial dividends.
(5) Goldman Sachs entered into an equity swap agreement which, upon the termination of the agreement on 8/13/2029, Goldman Sachs will pay to the counterparty any decrease in the price of the Common Shares below $9.45 per share and the counterparty will pay Goldman Sachs any increase in the price of the Common Shares above $9.45 per share, in each case, based on a notional amount of 93 Common Shares and any additional costs and charges including any payments with respect to financial dividends.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
GOLDMAN SACHS GROUP INC
200 WEST STREET
NEW YORK, NY 10282

X

GOLDMAN SACHS & CO. LLC
200 WEST STREET
NEW YORK, NY 10282

X


Signatures
/s/ Nathan R. Burby, Attorney-in-fact5/19/2020
**Signature of Reporting PersonDate

/s/ Nathan R. Burby, Attorney-in-fact5/19/2020
**Signature of Reporting PersonDate

Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Core Laboratories Charts.
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Core Laboratories Charts.